Skip to main content

Biotech valuations rise post-FDA leadership change

Make a pick
user-generated· price

Biotech valuations rise post-FDA leadership change

Market overview

After the FDA chief's appointment, biotech stocks will surge by 10% or more within 30 days due to improved regulatory clarity. Investors will anticipate faster drug approvals and fewer rejections.

price prediction market

Implied probability (Yes)
60%

Source: user-generated

More price markets

Browse all price markets →

No one's made a Conviction call on this yet. Be the first to call it →
Loading…